EMGE - Emergent Health Corp.


0.0001
0.000   100.000%

Share volume: 164,646
Last Updated: 03-03-2026
Wholesale/Wholesale – Drugs & Drug Proprietaries: -0.09%

PREVIOUS CLOSE
CHG
CHG%

$0.00
0.00
0.00%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
21%
Profitability 18%
Dept financing 18%
Liquidity 0%
Performance 30%
Performance
5 Days
0   0%
1 Month
0   0%
3 Months
0   0%
6 Months
0   0%
1 Year
-85.71%
2 Year
-88.89%
Key data
Stock price
$0.00
P/E Ratio 
N/A
DAY RANGE
$0.00 - $0.00
EPS 
N/A
52 WEEK RANGE
$0.00 - $0.00
52 WEEK CHANGE
-$85.71
MARKET CAP 
0.000
YIELD 
N/A
SHARES OUTSTANDING 
0.000
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
BETA 
0.00
PUBLIC FLOAT 
N/A
AVERAGE 10 VOLUME 
N/A
AVERAGE 30 VOLUME 
$164,646
Company detail
CEO:
Region: US
Website: emergenthealthcorp.com
Employees: 6
IPO year: 2008
Issue type:
Market: OTCM
Industry: Wholesale/Wholesale – Drugs & Drug Proprietaries
Sector: Wholesale Trade

Emergent Health Corp. develops and sells regenerative medicine, neutraceuticals, and phytonutritionals. Vita-Stim is a nutrient that enhances the immune system, nourishes stem cells, and maintains health. Hungarest is a diet aid that controls appetite in the brain and stomach.

Recent news